Synthesis, Crystal Structure and Antitumor Activity of 2-(3-Methyl-5-(methylthio)-4H-1,2,4-triazol-4-yl)isoindoline-1,3-dione①
2015-10-13ZHAOPeiLingHUMengJinDUANAnSUNXioMinYOUWenWei
ZHAO Pei-Ling HUMeng-Jin DUAN An-N SUN Xio-Min YOU Wen-Wei③
Synthesis, Crystal Structure and Antitumor Activity of 2-(3-Methyl-5-(methylthio)-4H-1,2,4-triazol-4-yl)isoindoline-1,3-dione①
ZHAO Pei-Lianga②HUMeng-Jina②DUAN An-NaaSUN Xiao-Minb③YOU Wen-Weia③
a(510515)b(510515)
The title compound 2-(3-methyl-5-(methylthio)-4H-1,2,4-triazol-4-yl)isoindoline- 1,3-dione(C12H10N4O2S,M= 274.30) has been synthesized by a three-step procedure including the cyclization, hydrazinolysis and substitution reactions, and its crystal structure was determined by X-ray single-crystal diffraction. The crystal belongs to the monoclinic system, space group21/with= 12.264(3),= 14.646(3),= 14.349(4) Å,= 91.69(3)°,= 0.255 mm-1,M= 274.30,= 2576.2(10) Å3,= 8,D= 1.414 g/cm3,(000) = 1136,= 0.0487 and= 0.1329 for 4048 observed reflections with> 2(). In addition, the preliminary bioassay suggested that the title compound 6 exhibits relatively good antitumor activity against HT-29 and MCF-7.
2-(3-methyl-5-(methylthio)-4H-1,2,4-triazol-4-yl)isoindoline-1,3-dione, synthesis, crystal structure, antitumor activity;
1 INTRODUCTION
Isoindoline-1,3-dione derivatives are an important class of heterocyclic structures found in many synthetic and natural occurring products[1-4], and have received considerable attention in recent years due to their remarkable spectra of biological activi- ties, such as antibacterial[5], antifungal[6], anticon- vulsant[7], anti-inflammatory[8], antimicrobial[9], her- bicidal[10], andantitumor properties[11]. In addition, it is well-known that the derivatives of 1,2,4-triazole always possess a wide range of biological activities including antifungal[12],insecticidal[13], antimicro- bial[14], antitumor[15], and antivascular[16]activities.
Based on the above considerations, and in a con- tinuation of our interest in the synthesis of nitrogen- containing heterocycles with anticancer activity[17-21], we developed an idea that incorporating 1,2,4-tri- azole ring with the isoindoline-1,3-dione moiety might result in new compounds with high biological activities. In this paper, we describe the synthesis of 2-(3-methyl-5-(methylthio)-4H-1,2,4-triazol-4-yl) isoindoline-1,3-dione using acetic acid and thiocar- bazide as the starting materials (Scheme 1), focusing on its crystal structure and antitumor activity.

Scheme 1. Synthetic route of the target compound 6
2 EXPERIMENTAL
2. 1 Instruments and reagents
Melting point was determined with an uncorrected Buchi B-545 melting point apparatus.1H NMR and13C NMR spectra were recorded on a Mercury-Plus 400 spectrometer in DMSO-d6or CDCl3with TMS as the internal reference. MS spectra were deter- mined using a Micromass ZQ4000 organic mass spectrometry. Elementary analyses were performed on a Vario EL III elementary analysis instrument. All of the solvents and materials were of reagent grade and purified as required.
2. 2 Synthesis
The general procedure for the synthesis of com- pound 6 is shown in Scheme 1. The key intermediate,4-amino-5-methyl-4H-1,2,4-triazole-3-thiol (3), was prepared in good yields according to our previously reported method[22].
Preparation of 2-(3-mercapto-5-methyl-4H-1,2,4- triazol-4-yl)isoindoline-1,3-dione (5): A solution of intermediate 3 (1.3 g, 10 mmol) and isobenzo- furan-1,3-dione 4 (1.63 g, 11 mmol) in glacial acetic acid (20 mL) was refluxed for about 2 h. After the reaction was complete according to TLC detection, the solution was slowly poured into 50 mL of water. The resulting mixture was stirred until the solid appeared. Then, after filtration, the obtained solid was dried and recrystallized from ethanol to afford compound 4Yield, 83%; m.p. 70~71 ℃.1H NMR (400 MHz, DMSO-d6): 2.32 (s, 3H, triazole-CH3), 8.05 (t,= 4.0 Hz, 2H, ArH), 8.12 (dd,= 3.4 Hz,= 5.0 Hz, 2H, ArH), 14.16 (s, 1H, SH).13C NMR (150 MHz, DMSO-d6):= 17.8, 125.0, 129.7, 136.4, 154.3, 163.4, 166.8. ESI-MS: m/z = 261.5 [M+1]+.
Preparation of 2-(3-methyl-5-(methylthio)-4H- 1,2,4-triazol-4-yl)isoindoline-1,3-dione (6): A mix- ture of 2-(3-mercapto-5-methyl-4H-1,2,4-triazol-4- yl)isoindoline-1,3-dione 5 (0.29 g, 1.1 mmol) and anhydrous K2CO3(0.16 g, 1.2 mmol) in dry acetone (8 mL) was stirred for 0.5 h, followed by the addi- tion of methyl iodide (0.14 g, 1.0 mmol). The reac- tion was continued for 3 h at room temperature, and then filtered off by suction. The solvent was eva- porated to give the crude product followed by chro- matography purification on silica using a mixture of petroleum ether and ethyl acetate (20:1) as an eluent to give the target compound 6 in the yield of 78%. m.p.: 113~115 ℃.1H NMR (400 MHz, CDCl3): 2.32 (s, 3H, triazole-CH3), 2.61 (s, 3H, SCH3), 7.91 (dd, J = 3.2 Hz, J = 5.6 Hz, 2H, ArH), 8.00 (dd, J = 3.2 Hz, J = 5.6 Hz, 2H, ArH).13C NMR (150 MHz, CDCl3):= 9.6, 15.4, 124.6, 128.8, 135.6, 151.6, 152.2, 162.0. EI-MS: m/z = 297.20 [M + Na]+, 275.15 [M+1]+. Anal. Calcd. (%) for C12H10N4O2S: C, 52.54; H, 3.67; N, 20.43; S, 11.69. Found (%): C, 52.37; H, 3.76; N, 20.15; S, 11.38.
2. 3 Crystal data and structure determination
A colorless crystal cultured from acetone with dimensions of 0.45mm × 0.40mm × 0.35mm was mounted on a glass fiber in a random orientation. The unit cell determination and data collection were performed with a Moradiation (= 0.71073 Å) on a Bruker Smart APEX-CCD diffractometer equipped with ascan mode in the range of 3.02≤≤27.48° at 293(2) K. A total of 26314 reflec- tions were collected with 5896 unique ones (int= 0.0509), of which 4048 observed reflections with> 2() were used in the succeeding refinements. The structure was solved by direct methods with SHE- LXS-97[23], and refined on2by full-matrix least- squares techniques with SHELXL-97 programs[24]. The hydrogen atoms were determined with theore- tical calculations. A full-matrix least-squares refine- ment gave the final= 0.0487 and= 0.1329 (= 1/[2(F2) + (0.0571)2+ 0.8295], where= (F2+ 2F2)/3), (Δ/)max= 0.000,= 1.033, (Δ)max= 0.246 and (Δ)min= –0.360 e/Å3.
3 RESULTS AND DISCUSSION
The structure of the title compound 6 was con- firmed by the1H NMR,13C NMR, EI-MS and ele- mental analysis. These spectroscopic data are in good agreement with the assumed structure, and its structure was further determined by X-ray single- crystal diffraction analysis. The selected bond lengths and bond angles are listed in Table 1, and hydrogen bond details in Table 2. The molecular structure of the title compound with atomic num- bering scheme is shown in Fig. 1, and Fig. 2 depicts the molecular packing in a unit cell.

Fig. 1 . Molecular structure of the title compound

Fig. 2 . Packing diagram of the title compound in a unit cell

Table 1. Selected Bond Lengths (Å) and Bond Angles (°)
Symmetry codes: #1: 1+,,; #2: 1–, –1/2+, 1/2–; #3:1–, 1/2+, 1/2–
As shown in Fig. 1, in the crystal structure of the title compound, two crystallographically indepen- dent molecules are found in the asymmetric unit. In 1,2,4-triazole system, the C(10)–N(2), C(10)–N(3), C(11)–N(2) and C(11)–N(4) bonds are significan- tly shorter than a normal single C–N bond (1.47 Å)[25]and longer than a C=N bond (1.28 Å)[26], which indicates significant electron delocalization in the triazole system. All ring atoms of the isoindoline system (N(1)/C(1)~C(8)) are essentially coplanar, with maximum deviations of 0.0514 Å for N(1) and –0.0339 Å for C(7). The dihedral angles made by the triazole ring with pyrrolidone and benzene rings are 86.24(3) and 86.84(2)°, respectively. Furthermore, the intramolecular C(17)–H(17)⋯O(2) and C(12)– H(12)⋯O(4) as well as intermolecular C(24)– H(24C)⋯O(2), C(21)–H(21C)⋯O(2) and C(12)– H(12A)⋯O(3) hydrogen bonds found in the title compound play a major role in stabilizing the molecule. It is worth noting that the crystal packing is further stabilized by two weak-stacking interactions, as evidenced by the relatively shorter distance between the centroids of the C(2)~C(7) (Cg3) and C(22)/C(23)/N(6)~N(8) (Cg6) rings in adjacent molecules (Cg3···Cg6 = 3.511(15) Å) and the C(10)/C(11)/N(2)~N(4) (Cg2) and C(14)~C(19) (Cg7) rings in neighboring molecules (Cg2···Cg7 = 3.796(12) Å). The sum of these inte- ractions results in the formation of a three-dimen- sional framework.
4 ANTITUMOR ACTIVITY
Theantitumor activity of the title com- pound 6 against HT-29 (human colon carcinoma cell line), MCF-7 (human breast cancer cell line) and HepG2 (human hepatocellular liver carcinoma cell line) was evaluated by the standard MTT assay[17]. 5-Fluorouracil (5-FU) was used as a positive control. As described in Table 3, the result of preliminary bioassay shows that compound 6 exhibits certain antitumor activity against HT-29 cell line and com- parable antitumor activity against MCF-7 with 5-FU. And further structural optimization is undergoing.

Table 3. In Vitro Antitumor Activity for the Title Compound 6
(1) Kantak, A. A.; Potavathri, S.; Barham, R. A.; Romano, K. M.; DeBoef, B. Metal-free intermolecular oxidative C–N bond formation via tandem C–H and N–H bond functionalization.2011, 133, 19960–19965.
(2) Ung, P. M.; Dunbar, J. B.; Jr-Gestwicki, J. E.; Carlson, H. A. An allosteric modulator of HIV-1 protease shows equipotent inhibition of wild-type and drug-resistant proteases.2014, 57, 6468–6478.
(3) Zhao, P. L.; Ma, W. F.; Duan, A. N.; Zou, M.; Yan, Y. C.; You, W. W.; Wu, S. G. One-pot synthesis of novel isoindoline-1,3-dione derivatives bearing 1,2,4-triazole moiety and their preliminary biological evaluation..2012, 54, 813–822.
(4) Ignasik, M.; Bajda, M.; Guzior, N.; Prinz, M.; Holzgrabe, U.; Malawska, B. Design, synthesis and evaluation of novel 2- (aminoalkyl)-isoindoline-1,3-dione derivatives asdual-binding site acetylcholinesterase inhibitors.2012, 345, 509–516.
(5) Bansode, T. N.; Shelke, J. V.; Dongre, V. G. Synthesis and antimicrobial activity of some new N-acyl substituted phenothiazines.2009, 44, 5094–5098.
(6) Santos, J. L.; Yamasaki, P. R.; Chin, C. M.; Takashi, C. H.; Pavan, F. R.; Leite, C. Q. Synthesis and in vitro anti mycobacterium tuberculosis activity of a series of phthalimide derivatives.2009, 17, 3795–3799.
(7) Kamiński, K.; Obniska, J.; Wiklik, B.; Atamanyuk, D. Synthesis and anticonvulsant properties of new acetamide derivatives of phthalimide, and its saturated cyclohexane and norbornene analogs.2011, 46, 4634–4641.
(8) Matalka, K. Z.; Alfarhoud, F.; Qinna, N. A.; Mallah, E. M.; Abu-Dayyih, W. A.; Muhi-eldeen, Z. A. Anti-inflammatory aminoacetylenic isoindoline-1,3-dionederivatives modulate cytokines production from different spleen cell populations.2012, 14, 296–301.
(9) Shivakumar, L.; Shivaprasad, K.; Revanasiddappa, H. D. Synthesis, spectroscopic characterization, antimicrobial, DNA binding and oxidative-induced DNA cleavage activities: new oxovanadium(IV) complexes of 2-(2-hydroxybenzylideneamino)isoindoline-1,3-dione.. 2012, 97, 659–666.
(10) Jiang, L. L.; Zuo, Y.; Wang, Z. F.; Tan, Y.; Wu, Q. Y.; Xi, Z.; Yang, G. F. Design and syntheses of novel-(benzothiazol-5-yl)-4,5,6,7-tetrahydro-1-isoindole-1,3(2)-dione and-(benzothiazol-5-yl)isoindoline-1,3-dione as potent protoporphyrinogen oxidase inhibitors.2011, 59, 6172–6179.
(11) Jin, K.; Zhang, X.; Ma, C.; Xu, Y.; Yuan, Y.; Xu, W. Novel indoline-2,3-dione derivatives as inhibitors of aminopeptidase N (APN).2013, 21, 2663–2670.
(12) Cao, X.; Sun, Z.; Cao, Y.; Wang, R.; Cai, T.; Chu, W.; Hu, W.; Yang, Y. Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linkedtriazoles with good activity and water solubility.2014, 57, 3687–3706.
(13) Hull, J. W.; Romer, D. R.; Podhorez, D. E.; Ash, M. L.; Brady, C. H. Development of potential manufacturing routes for substituted thiophenes--preparation of halogenated 2-thiophenecarboxylic acid derivatives as building blocks for a new family of 2,6-dihaloaryl 1,2,4-triazole insecticides.2007, 3, 1–8.
(14) Al-Abdullah, E. S.; Asiri, H. H.; Lahsasni, S.; Habib, E. E.; Ibrahim, T. M.; El-Emam, A. A. Synthesis, antimicrobial, and anti-inflammatory activity, of novel S-substituted and N-substituted 5-(1-adamantyl)-1,2,4-triazole-3-thiols.2014, 8, 505–518.
(15) Kamel, M. M.; Megally-Abdo, N. Y. Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents.2014, 86C, 75–80.
(16) Romagnoli, R.; Baraldi, P. G.; Salvador, M. K.; Prencipe, F.; Bertolasi, V.; Cancellieri, M.; Brancale, A.; Hamel, E.; Castagliuolo, I.; Consolaro, F.; Porcù, E.; Basso, G.; Viola, G. Synthesis, antimitotic and antivascular activity of 1-(3΄,4΄,5΄-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles.2014, 57, 6795–6808.
(17) Zhao, P. L.; Duan, A. N.; Zou, M.; Yang, H. K.; You, W. W.; Wu, S. G. Synthesis and cytotoxicity of 3,4-disubstituted-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazoles and novel 5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives bearing 3,4,5-trimethoxyphenyl moiety.2012, 22, 4471–4474.
(18) Zhao, P. L.; Wang, L.; Zhu, X. L.; Huang, X.; Zhan, C. G.; Wu, J. W.; Yang, G. F. Subnanomolar inhibitor of cytochrome bc1 complex designed by optimizing interaction with conformationally flexible residues.2010, 132, 185–194.
(19) Yang, H. K.; Xu, W. F.; Duan, A. N.; Zhao, P. L.; You, W. W. Syntheses and biological activities of novel imine and imide derivatives bearing 1,2,4-triazole moiety.Chem. J. Chin. U. 2014, 35, 555–563.
(20) Zhao, P. L.; Li, J.; Yang, G. F. Synthesis and insecticidal activity of chromanone and chromone analogues of diacylhydrazines.2007, 15, 1888–1895.
(21) Zhao, P. L.; Wang, F.; Zhang, M. Z.; Liu, Z. M.; Huang, W.; Yang, G. F. Synthesis, fungicidal, and insecticidal activities of beta-Methoxyacrylate-containing N-acetyl pyrazoline derivatives.2008, 56,10767–10773.
(22) Zhao, P. L.; Zhang, B.; Wang, Y. Z.; Yang, G. F. Synthesis and fungicidal activities of novel analogues of strobilurins containing 1,2,4-triazol moiety2008, 28, 875–880.
(23) Sheldrick, G. M.. University of Göttingen, Germany 1997.
(24) Sheldrick, G. M.. University of Göttingen, Germany 1997.
(25) Chen, X. B.; Li, K.; Shi, D. Q. Synthesis and crystal structure of N-(1,3,4-thiadiazol-2-yl)-1-[1-(6-chloropyridin-3-yl)methy]-5-methyl-lH- [1,2,3]triazol-4-carboxamide.2008, 27, 1389–1392.
(26) Wang, Z. X.; Jian, F. F.; Duan, C. Y.; Bai, Z. P.; You, X. Z. 2-(2-Hydroxybenzylidene)-1-(2-picoloyl)hydrazine Hemihydrate.. 1998, C54, 1927–1929.
17 September 2014; accepted 12 November 2014 (CCDC 1032363)
① The project was supported by the National Natural Science Foundation of China (21102069 and 21372113), and the Project of Science and Technology New Star in Zhujiang Guangzhou city (No. 2012J2200051)
② Co-first authors due to their equal contribution
. Sun Xiao-Min, sunxiaomin198001@163.com; You Wen-Wei, professor, majoring in medicinal chemistry. E-mail: youww@smu.edu.cn
10.14102/j.cnki.0254-5861.2011-0513
杂志排行
结构化学的其它文章
- Crystal Structure, Photoluminescence, and TheoreticalStudies of Dihydropyran Derivatives①
- Charge Transfer Properties of Organic Semiconductor Molecules of Perylene Derivatives①
- Synthesis and Structural Characterization of Organophosphorus Ylide-1-(3-nitrophenyl)-2-(triphenyl phosphoranylidene)ethanone①
- Isolation and Crystal Structure of Ent-kaurane Diterpenes from Rubus corchorifolius L. f.①
- Synthesis, Crystal Structure, and Magnetic Properties of a New Dinuclear Iron Complex with Schiff Base Ligand①
- Synthesis, Crystal Structure and Antitumor Activity of 4-(tert-butyl)-5-(1H-1,2,4-triazol-1-yl)-N-(2-hydroxy-3,5-diiodinebenzyl)-thiazol-2-amine①
